935 related articles for article (PubMed ID: 18387161)
41. Coagulation and fibrinolysis factors in dialysis patients with and without ischemic heart disease.
Oda H; Ohno M; Ohashi H
Adv Perit Dial; 2000; 16():152-5. PubMed ID: 11045282
[TBL] [Abstract][Full Text] [Related]
42. Relationship of cardiac troponin T and procoagulant activity in unstable angina.
Giannitsis E; Bardorff MM; Schweikart S; Wiegand U; Kampmann M; Katus HA
Thromb Haemost; 2000 Feb; 83(2):224-8. PubMed ID: 10739377
[TBL] [Abstract][Full Text] [Related]
43. Hemostasis during normal pregnancy and puerperium.
Hellgren M
Semin Thromb Hemost; 2003 Apr; 29(2):125-30. PubMed ID: 12709915
[TBL] [Abstract][Full Text] [Related]
44. Coagulation and fibrinolytic activity in Behçet's disease.
Hampton KK; Chamberlain MA; Menon DK; Davies JA
Thromb Haemost; 1991 Sep; 66(3):292-4. PubMed ID: 1745999
[TBL] [Abstract][Full Text] [Related]
45. Severe chronic urticaria is associated with elevated plasma levels of D-dimer.
Asero R; Tedeschi A; Riboldi P; Griffini S; Bonanni E; Cugno M
Allergy; 2008 Feb; 63(2):176-80. PubMed ID: 17961199
[TBL] [Abstract][Full Text] [Related]
46. Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina?
Itakura H; Sobel BE; Boothroyd D; Leung LL; Iribarren C; Go AS; Fortmann SP; Quertermous T; Hlatky MA;
Am Heart J; 2007 Dec; 154(6):1059-64. PubMed ID: 18035075
[TBL] [Abstract][Full Text] [Related]
47. Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis.
Stein SF; Harker LA
J Lab Clin Med; 1982 Feb; 99(2):217-30. PubMed ID: 7061918
[TBL] [Abstract][Full Text] [Related]
48. Excess soluble urokinase-type plasminogen activator receptor in the plasma of dialysis patients correlates with increased fibrinolytic activity.
Pawlak K; Pawlak D; Mysliwiec M
Thromb Res; 2007; 119(4):475-80. PubMed ID: 16828495
[TBL] [Abstract][Full Text] [Related]
49. Platelet, antithrombin, and fibrinolytic activities in taurine-deficient and taurine-replete cats.
Welles EG; Boudreaux MK; Tyler JW
Am J Vet Res; 1993 Aug; 54(8):1235-43. PubMed ID: 8214889
[TBL] [Abstract][Full Text] [Related]
50. Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome.
Oral B; Mermi B; Dilek M; Alanoğlu G; Sütçü R
Gynecol Endocrinol; 2009 Feb; 25(2):110-6. PubMed ID: 19253106
[TBL] [Abstract][Full Text] [Related]
51. The effect of long-term, low-dose tranexamic acid treatment on platelet dysfunction and haemoglobin levels in haemodialysis patients.
Sabovic M; Zupan IP; Salobir B; Zupan I; Cernelc P; Lavre J; Vujkovac B
Thromb Haemost; 2005 Dec; 94(6):1245-50. PubMed ID: 16411401
[TBL] [Abstract][Full Text] [Related]
52. Coagulation and fibrinolytic activity in patients with acute cerebral infarction.
Li F; Zhang G; Zhao W
Chin Med J (Engl); 2003 Mar; 116(3):475-7. PubMed ID: 12781064
[TBL] [Abstract][Full Text] [Related]
53. Differential effects of reconstituted high-density lipoprotein on coagulation, fibrinolysis and platelet activation during human endotoxemia.
Pajkrt D; Lerch PG; van der Poll T; Levi M; Illi M; Doran JE; Arnet B; van den Ende A; ten Cate JW; van Deventer SJ
Thromb Haemost; 1997 Feb; 77(2):303-7. PubMed ID: 9157586
[TBL] [Abstract][Full Text] [Related]
54. [Responses to surgical stress in blood coagulation and fibrinolysis, platelet counts and thromboxane B2 after esophageal cancer operation].
Shinohara M; Kurokawa H; Yoshihara Y; Kokubu S; Kusano T; Horie K; Murakami N; Nagai K; Nara N
Rinsho Byori; 1997 Feb; 45(2):179-84. PubMed ID: 9121003
[TBL] [Abstract][Full Text] [Related]
55. Quantitative and temporal differences in coagulation, fibrinolysis and platelet activation after on-pump and off-pump coronary artery bypass surgery.
Vallely MP; Bannon PG; Bayfield MS; Hughes CF; Kritharides L
Heart Lung Circ; 2009 Apr; 18(2):123-30. PubMed ID: 19081297
[TBL] [Abstract][Full Text] [Related]
56. Activation of the fibrinolytic system in patients with coronary artery disease and hyperfibrinogenemia.
Stein D; Heins M; Schoebel FC; Pels K; Jax TW; Stiegler H; Reinauer H; Strauer BE; Leschke M
Thromb Haemost; 1997 May; 77(5):970-4. PubMed ID: 9184412
[TBL] [Abstract][Full Text] [Related]
57. The fibrinolytic system in chronic renal failure.
Lottermoser K; Petras S; Pöge U; Fimmers R; Hertfelder HJ; Schiermeyer B; Vetter H; Düsing R
Eur J Med Res; 2001 Sep; 6(9):372-6. PubMed ID: 11591527
[TBL] [Abstract][Full Text] [Related]
58. Elastase- and plasmin-mediated fibrinolysis in rheumatoid arthritis.
Carmassi F; De Negri F; Morale M; Puccetti R; Chung SI
Int J Tissue React; 1994; 16(2):89-93. PubMed ID: 7960505
[TBL] [Abstract][Full Text] [Related]
59. [Tissue plasminogen activator antigen (t-PA Ag) and tissue plasminogen activator inhibitor (PAI-1) in the course of hemodialysis in patients with chronic renal failure].
Piatkowska M; Kotschy M; Nartowicz E; Rajewski W
Pol Merkur Lekarski; 1997 Jan; 2(9):205-7. PubMed ID: 10907030
[TBL] [Abstract][Full Text] [Related]
60. Relationship between gender difference in intravascular aggregation of platelets and the fibrinolytic pathway in the rat.
Oyekan AO; Botting JH
Arch Int Pharmacodyn Ther; 1991; 313():176-92. PubMed ID: 1816761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
